Market Place
Sourcing Support
CytomX to Present Data for Conditionally Activated Interferon Alpha-2b
30 Oct 2023 //
GLOBENEWSWIRE
BetterLife Initiates Preclinical Study of AP-003 in Delta Variant of SARS-CoV-2
25 Aug 2021 //
GLOBENEWSWIRE
AOP Orphan Pharmaceuticals presents latest analysis on BESREMi at EHA 2021
01 Jul 2021 //
PRESS RELEASE
Schering`s Peginterferon Alfa-2B Receives Approval in US
08 Jan 2019 //
FDA
Schering`s Peginterferon Alfa-2B Receives Supplemental Approval in US
21 Dec 2018 //
FDA
Seven medicines leap closer to EU approval
18 Dec 2018 //
PHARMA TIMES
PharmaEssentia, AOP Orphan Receive +ve CHMP Opinion For Ropeginterferon alfa-2b
17 Dec 2018 //
PR NEWSWIRE
Meeting highlights from the CHMP 10-13 December 2018
14 Dec 2018 //
Schering’s Intron (Interferon Alfa-2b) Receives Supplemental Approval In US
13 Jun 2017 //
FDA
Russia approves first ever biosimilar of Serono’s MS drug Rebif
03 Mar 2017 //
BIOPHARMA
Anvisa suspending imports of Chinese inputs
11 Nov 2015 //
ANVISA
Roche cuts Hepatitis C drug cost by 65% for govt institutions
16 Jun 2015 //
BUSINESS STANDARD
CA Panel: Gilead`s Harvoni Cost-Effective At $95K, But Only Affordable At Half the Price
15 Dec 2014 //
FIERCEPHARMA
Class Action Lawsuit Challenges the Exorbitant Pricing of Gilead`s Hepatitis-C Drug Sovaldi
09 Dec 2014 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.